2021 Bupa Health Foundation’s Emerging Health Researcher Award (Mental Health & Wellbeing) – CALL FOR NOMINATIONS

Funding, Prizes and Awards – 21 September 2021

2021 Bupa Health Foundation’s Emerging Health Researcher Award (Mental Health & Wellbeing) – CALL FOR NOMINATIONS

Nominations close on Monday 11 October 2021 at 9:00AM (AEDT)

The Bupa Health Foundation is seeking nominations for its 2021 Emerging Health Researcher Award.

Offered once a year, this award recognises the valuable contribution early career researchers (no more than 5 years post PhD) make toward improving health outcomes for all Australians. This year, the $25,000 Award is open to applications from researchers focused on improving mental health and wellbeing and/or the link between environmental and human health.

Five finalists will be awarded $5,000 with the eventual award winner receiving an additional $20,000. Five Commendation awards of $1,000 are also awarded. Total prize pool is expected to be $50,000.

This is the 10th year the Bupa Foundation has offered the Award, with Dr Jin Han of The Black Dog Institute receiving the grant in 2020.

Eligibility Criteria

  • An early career researcher – anytime from qualification but no more than 5 years past PhD or research higher degree. (Exceptions will be granted for career disruption due to carer’s responsibilities, illness, disability or COVID-19).
  • An Australian Citizen or Permanent Resident
  • Currently engaged in applied research activities that align with the focus of the Bupa Health Foundation.

Who can nominate?
Nominations must be completed by research supervisors and/or department heads who are directly involved in the work of the researcher. Organisational approval of nominations is required.

What is the BUPA Health Foundation looking for in a nomination?
Nominations should clearly detail information about the Emerging Researcher, their area of interest, an overview of their research area and its potential impact on the health of Australians.

Award criteria and the nomination form are available at https://www.bupa.com.au/about-us/bupa-health-foundation (scroll to middle of page). Note: All nominations must be submitted using the online form. Email and post applications will not be accepted.

Nominations close on Monday 11 October 2021 at 9:00AM (AEDT).

Finalists will be contacted via phone and email by 1 November 2021. The overall winner will be announced mid-November 2021.

Should you have any queries, please contact the Bupa Health Foundation at foundation@bupa.com.au.

Pfizer Global Medical Grants Request for Proposals (RFP) Addressing Knowledge Gaps in Alopecia Areata and Atopic Dermatitis

Funding, Prizes and Awards – 14 September 2021

Pfizer Global Medical Grants Request for Proposals (RFP) Addressing Knowledge Gaps in Alopecia Areata and Atopic Dermatitis

Application Due Date: Monday 4 October 2021

Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g., research, quality improvement, or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s GMG competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a general area of interest, sets timelines for review and approval, and uses an internal Pfizer review process to make final grant decisions. Organizations are invited to submit an application addressing the knowledge gaps as outlined in the specific RFP.

For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer must not be involved in any aspect of project development, nor the conduct of the independent education program.

Specific Area of Interest: Through this RFP it is our intent to support educational projects that focus on addressing knowledge and practice gaps specific to the recognition, diagnosis, treatment, and overall care management of atopic dermatitis (AD) and/or Alopecia Areata (AA). Projects that will be considered for Pfizer support should focus on increasing the knowledge and understanding of:

  1. the pathophysiology of AA and/or AD with specific focus on immunologic pathways
  2. the epidemiology of the disease(s), including an understanding of the risk factors for the development of the disease(s), comorbidities, and safety events relevant to systemic therapies
  3. understanding the clinical manifestation of AD/AA, including a holistic review of the burden of disease (e.g. psychosocial burden and associated autoimmune disorders)
  4. new advances in the treatment pathways of AA and/or AD
  5. mechanism of action of treatments in AA and/or AD
  6. the benefit:risk profile of AA and/or AD treatments. 

Refer to complete details in the full RFP document. If you have questions regarding this RFP, please direct them in writing to Amanda Solis, Grant Officer (amanda.solis@pfizer.com).

VicHealth Early Career Fellowships

Funding, Prizes and Awards – 14 September 2021

VicHealth Early Career Fellowships

Funder deadline: 12 noon, Monday 4 October 2021

As part of our commitment to improving the health and wellbeing of all Victorians, VicHealth has established a competitive postdoctoral fellowship program to support excellence in early-career research. VicHealth is investing in new targeted research fellowships over the next 3 years to ensure our programs and investments continue to best meet the needs of Victorians.

VicHealth is excited to open a second round of fellowships in 2021. We will provide a salary contribution to fund up to 4 early-career research fellows to undertake a 3-year full-time research project related to one of the research projects below.

The fellowships program is a unique opportunity for early-career researchers to immerse themselves in VicHealth’s work. Successful fellows will integrate with the VicHealth team to support the health and wellbeing of Victorians and build evidence to inform policy and practice change.

Applications are invited from early-career researchers with expertise related to one of the research projects below:

Future Healthy Countdown Fellowship (1 fellow)
This fellow will lead the development of an innovative approach to tracking children’s health and wellbeing to influence policy and practice change. This research fellow will develop and implement an approach to monitoring progress towards improving health and wellbeing outcomes for Australia’s children and young people.

Along with the international community, Australia is working towards the Sustainable Development Goals, in the hopes of achieving health for all by 2030. At VicHealth, we envision a Victoria where no young person is denied a future that is healthy, regardless of their postcode, bank balance or background. The tool developed through this fellowship will track progress towards achieving this vision.

Utilising principles and approaches informed by the Lancet NCD Countdown 2030, this fellow will work with VicHealth and a range of partners to develop the methods, system and approach to define and monitor progress. It is expected that the Countdown will demonstrate national-level statistics, but will allow data from Victoria to be disaggregated. This will provide useful insights for the Victorian state government and local councils on the strategies required to reduce the likelihood of children developing non-communicable diseases later in life, including cardiovascular disease and obesity.

Harmful Industries Monitoring Hub Fellowship (up to 3 fellows)
These fellows will help to reduce the influence and impact of harmful industries on the health and wellbeing of Victorians and Australians. Successful fellows will gather and report intelligence on harmful industry activity in Australia, with a focus on the alcohol, gambling, unhealthy food and sugary drinks industries.

A declaration is required to receive further essential information about this research project to inform an application. Please email researchgrants@vichealth.vic.gov.au with the following information:

  • Your name and contact details
  • Current role/title
  • Qualification/s and areas of interest
  • Declaration about any past 5-year or current relationships with the tobacco industry (including industry-funded bodies or foundations).
  • If none please state: ““I declare that neither I, my primary research advisor, nor my organisation** has any current, planned or past 5-year relationships with the tobacco industry”.
  • Declaration about any past 12-month or current relationships with the alcohol, gambling, unhealthy food or sugary drinks industry (includes products, manufacturers, retailers as well as lobby groups and industry-funded bodies or foundations).
  • If none, please state: “I declare that neither I, my primary research advisor, nor my organisation** has any current, planned or past 12-month relationships with the unhealthy food, sugary drink, alcohol or gambling industries”.
  • **For universities, you must declare relationships that exist within your school at a minimum. It is preferable however, that relationships with the relevant faculty/school/college are also declared.
  • The final date to request further information is Monday 20 September.

Further information including, application guidelines, eligibility criteria and FAQs is available on the website.

FMNHS Senior Postdoctoral Fellowships 2022 – Applications Now Open

Funding, Prizes and Awards – 14 September 2021

FMNHS Senior Postdoctoral Fellowships 2022 – Applications Now Open

Submissions close on Thursday 11 November 2021 at 5:00PM (AEDT)

The Faculty of Medicine, Nursing and Health Sciences (FMNHS) will provide competitive funding for researchers who have applied for fellowship support in 2021 but have been unsuccessful in obtaining salary support.

These FMNHS Senior Postdoctoral Fellowships (SPF) are targeted at outstanding candidates who have the clear potential to be successful in external career fellowship schemes. These candidates will usually have four to six years of postdoctoral experience, however, this is a guide only.

Under the SPF 2022 scheme, it is expected that the applicant will have been invited to interview for the 2021 external fellowship application (if this is a part of the selection process for the external award) and will have received positive assessor reports.

For further information and to apply, please click here.  (You must be signed into Google with your Monash account to access further information)  

Submissions close on Thursday 11 November 2021 at 5:00PM (AEDT).

Queries about this scheme should be directed to the Faculty Research Office by email to medicine.research@monash.edu.

EOIs Now Open – SMICS 2021/22 Funding Program

Funding, Prizes and Awards – 14 September 2021

EOIs Now Open – SMICS 2021/22 Funding Program

EOIs Due by 5:00pm Sunday 10 October 2021

The SMICS 2021/22 Funding Program provides eligible health services with funding to support innovative project applications designed to have a positive impact on the quality of patient care and experience. It encourages effective partnerships and collaboration between health providers and consumers to improve coordination, accessibility and quality of care provided to better support all people affected by cancer.

Projects must align with the Victorian Cancer Plan 2020-2024 and the VICS 2021-2022 Priorities.

Funding is available for:

  • Quality & Service Improvement (up to $100,000 per project)
  • Service/Process Redesign (up to $30,000 per project)

All Expressions of Interest for the SMICS 2021-2022 Funding Program must be received by 5:00pm AEST on 10 October 2021 by email to SMICS.Quality@monashhealth.org with ‘SMICS FUNDING PROGRAM 2021’ in the email header.

Applicants must use the relevant EOI template, and follow the application process as outlined in the corresponding guidelines. Applications that do not go through this process will be deemed ineligible for funding.

Note: Shortlisted applicants will be invited to pitch their project to an assessment panel on Thursday 21 October 2021 between 3:00pm and 6:00pm AEST. Applicants are to ensure their availability at this time.

For further information, contact Nell Sproule, Quality Manager at SMICS.Quality@monashhealth.org

2022 Johnson & Johnson WiSTeM2D Scholars Award – EOI Closing Soon

Funding, Prizes and Awards – 7 September 2021

2022 Johnson & Johnson WiSTeM2D Scholars Award – EOI Closing Soon

Faculty Research Office Deadline: 5:00pm Monday 13 September 2021

The Johnson & Johnson Scholars Program aims to fuel the development of female STEM2D leaders and feed the STEM2D talent pipeline by awarding and sponsoring women at critical points in their research careers, in each of the STEM2D disciplines:
  • Science
  • Technology
  • Engineering
  • Math
  • Manufacturing
  • Design
The awards will fund one woman per discipline (worldwide) who has completed her advanced degree, who is working as a Senior Lecturer or Lecturer (or other appointment that could be equivalent to “Assistant Professor” in the USA) and who is not yet tenured at an accredited university or design institution. Adjunct staff are not eligible. The Award is for $150,000 USD over three years.
For more details about the opportunity, please see the call page and FAQs.
Internal FMNHS EOI Process
Monash University may only submit one application per each of the six categories.  The Faculty of Medicine, Nursing and Health Sciences is calling for expressions of interest (EOIs), to determine the lead applicant in each category.
  • Each Faculty can nominate up to 6 applicants, one from each area of focus.
  • There will be a Faculty and cross-faculty review process to select those invited to proceed to full proposal.
  • Please provide an abstract of 500 words or less and a CV (3 pages) and your nominated discipline to medicine.research@monash.edu on or before 5pm on Monday 13 September 2021.
  • No letters are required for the EOI.
  • An application in Pure is not required for the EOI.
Process for invitation to full proposal
  • On conclusion of cross-faculty review process for the EOI, successful shortlisted applicants will be notified of their submission outcome by the Monash Research Office (MRO).
  • Selected applicants will be invited to apply to Johnson & Johnson using the following weblink.
  • Selected applicants will need to create an account and follow the instructions for submission (refer to the FAQ and the General Terms).
  • The selected applicants must ensure that they follow the funder’s requirements for submission (such as font size and page limit) as the MRO will not be able to provide compliance checks due to tight timelime.
  • A letter of recommendation from the relevant Head of Department/School will be required at that stage.
  • Selected applicants also need to create a Pure record and inform MRO of the Pure ID by 21/09/21, 12pm (MRO-applications@monash.edu)
For your information, please find attached some screenshots from the submission portal.
Key Dates
13 September 2021: Completed EOI (abstract of 500 words or less and attached CV, 3 pages) due to Faculty Research Office (medicine.research@monash.edu)
20 September 2021: Applicants notified of EOI submission outcomes (approximate date only)
27 September 2021: Funder’s application closing date (09:00 Honolulu Standard Time)


Further information is available on Research Professional